Maravai LifeSciences Corp (MRVI): Net earnings per share (EPS TTM)

Maravai LifeSciences Holdings, Inc. (MRVI) - corporate logo

Effective management at Maravai LifeSciences (MRVI) ensures high returns through the supply of components for mRNA therapies. Net income per share over the last four quarters on GURU.Markets demonstrates inflation adaptation, where the value of -0.45 characterizes this level. Maravai LifeSciences (MRVI) leads in the synthesis of pure nucleic acids through R&D while adhering to strict environmental regulations for laboratory waste disposal.

MRVI Maravai LifeSciences Net earnings per share for the last four quarters (07/04/2022 - 11/18/2026)

Summary analytical data breakdowns for Maravai (MRVI)

General company analysis:maravai.com (MRVI)
Manufactured products of Maravai LifeSciences Corp

This indicator measures the real equity value of the business by calculating annual net income without the impact of share issuance, allowing for an assessment of true capital generation efficiency. For Maravai LifeSciences (MRVI), the rolling net income per share reflects the monetization of CleanCap patents and integration into pharmaceutical programs, confirming the company's fundamental resilience in the face of market volatility.

Competitors of Maravai LifeSciences (MRVI)

agilent.com - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Quest Diagnostics Inc. DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months revvity.com|Earnings per share for the last twelve months BIO|Net earnings per share (EPS TTM) NNNN|SHC - Net earnings per one share for the last twelve months|Quidel Corporation - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) OPKO Health Corp. OPK|CDNA - Earnings per share for the last twelve months|FLGT: Earnings per share for the last twelve months|LAB: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cytek Biosciences Inc (CTKB)|Net earnings per share for the last 12 months OSUR|Earnings per share for the last 12 months XGN (Exagen)|Net earnings per share (EPS TTM) MDXH|LUCD (Lucid Diagnostics Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PRE (Prenetics Global)|Earnings per share for the last four quarters IMDX (imdxinc.com)|TRIB: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months ProPhase Labs, Inc.|AIMD: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months codiagnostics.com (CODX)|Net earnings per share for the last 12 months HSCS|BMRA: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CDIO|Net earnings per share for the last four quarters Onconetix Corporation|Net earnings per share (EPS TTM) VRAX (Virax Biolabs Group)|Net earnings per share for the trailing year bluejaydx.com|AWH: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Accelerate Diagnostics, Inc. AXDX|CNTG (CENTOGENE) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months ENZ|FRES: Net earnings per share for the last four quarters|Earnings per share for the last twelve months GENE|Net earnings per share for the last 12 months ME (23andMe Holding Co)|PMD - Net earnings per one share for the last twelve months